On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Bayer Pharma AG's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€988k · 21 projects
- Horizon 2020€353k · 9 projects
- Horizon Europe€0 · 1 project
Projects
31 EU-funded projects, newest first. Bayer Pharma AG led 1 of them as coordinator. Each links to the official record.
- BRIDGE-AIAssociated partner
BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- CaReSyAnPartner
Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease
Horizon 2020 · 2018–2021 · Project on CORDIS ↗
- HARMONYPartner
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
Horizon 2020 · 2017–2023 · Project on CORDIS ↗
- IB4SD-TRISTANPartner
Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106
Horizon 2020 · 2017–2024 · Project on CORDIS ↗
- PREFERPartner
Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966
Horizon 2020 · 2016–2022 · Project on CORDIS ↗
- BEAt-DKDPartner
Biomarker Enterprise to Attack DKD - Sofia ref.: 115974
Horizon 2020 · 2016–2023 · Project on CORDIS ↗
- ENLIGHT-TENPartner
European Network linking informatics and genomics of helper T cells
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€104ktheir share - ADAPT-SMARTPartner
Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
- IDEASPartner
Improving Design, Evaluation and Analysis of early drug development Studies
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€249ktheir share - MAGICBULLETPartner
Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
- WEB-RADRPartner
Recognising Adverse Drug Reactions
FP7 (2007 to 2013) · 2014–2017 · Project on CORDIS ↗
- €254ktheir share
- GETREALPartner
Incorporating real-life clinical data into drug development
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
- RADOXPartner
RADical reduction of OXidative stress in cardiovascular diseases
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€95ktheir share - CHEM21Partner
Chemical Manufacturing Methods for the 21st Century Pharmaceutical Industries
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
- ABIRISKPartner
Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk
FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗
- EUPATIPartner
European Patients' Academy on Therapeutic Innovation
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
- IONTRACPartner
Ion Transport Proteins in Control of Cancer Cell Behaviour
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€234ktheir share - EHR4CRPartner
Electronic Health Record systems for Clinical Research
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
- PREDECTPartner
New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
- EPC-TM-NETPartner
Targeting the tumour microenvironment to improve pancreatic cancer prognosis
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€76ktheir share - ONCOTRACKCoordinator
OncoTrack - Methods for systematic next generation oncology biomarker development
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
- PREDICTPartner
Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics
FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗
€329ktheir share - MARCARPartner
bioMARkers and molecular tumor classification for non-genotoxic CARcinogenesis
FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗
- ETOXPartner
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗
- SAFESCIMETPartner
European Modular Education and Training Programme in Safety Sciences for Medicines
FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗
- EMTRAINPartner
European Medicines Research Training Network
FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗
- PROTECTPartner
Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium
FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
- EU2PPartner
European programme in Pharmacovigilance and Pharmacoepidemiology
FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗
- SAFE-TPartner
SAFER AND FASTER EVIDENCE-BASED TRANSLATION
FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
- PHARMATRAINPartner
Pharmaceutical Medicine Training Programme
FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Novartis Pharma AGSwitzerland · 16 shared projects
- Astrazeneca ABSweden · 15 shared projects
- Janssen Pharmaceutica NVBelgium · 15 shared projects
- Glaxosmithkline Research & Development LimitedUnited Kingdom · 15 shared projects
- F. Hoffmann-La Roche AGSwitzerland · 14 shared projects
- Pfizer LimitedUnited Kingdom · 14 shared projects
- Boehringer Ingelheim InternationalgmbhGermany · 12 shared projects
- Novo Nordisk A/SDenmark · 11 shared projects
- Sanofi-Aventis Recherche & DeveloppementFrance · 11 shared projects
- Eli Lilly and Company LtdUnited Kingdom · 11 shared projects
- AmgenBelgium · 10 shared projects
- Merck Kommanditgesellschaft Auf AktienGermany · 9 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 8 shared projects
- Medizinische Universitaet WienAustria · 8 shared projects
- H. Lundbeck ASDenmark · 7 shared projects
- Karolinska InstitutetSweden · 6 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- RNA
- adverse drug reactions
- angiology
- artificial intelligence
- autoimmune diseases
- big data
- biocatalysis
- bioreactors
- business models
- cardiovascular diseases
- cell biology
- colorectal cancer
- data mining
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
